http://healthandprostate.com Benign Prostatic Hyperplasia - Prostate Cancer - Prostatitis Tue, 20 Jul 2010 08:02:22 +0000 http://backend.userland.com/rss092 en (British Approved Name, US Adopted Name, rINN) Drug Nomenclature International Nonproprietary Names (INNs) in main languages (French, Latin, Russian, and Spanish): Synonyms: Flutamid; Flutamida; Flutamidas; Flutamidi; Flutamidum; Sch-13521 BAN: Flutamide USAN: Flutamide INN: Flutamide [rINN (en)] INN: Flutamida [rINN (es)] INN: Flutamide [rINN (fr)] INN: Flutamidum [rINN (la)] INN: Флутамид [rINN (ru)] Chemical name: α´,α´,α´-Trifluoro-4´-nitroisobutyro-m-toluidide; α,α,α-Trifluoro-2-methyl-4´-nitro-m-propionotoluidide Molecular formula: ... http://healthandprostate.com/index.php/drugs/flutamide-2 (British Approved Name, rINN) Drug Nomenclature International Nonproprietary Names (INNs) in main languages (French, Latin, Russian, and Spanish): Synonyms: Aminoglutethimid; Aminoglutethimidum; Aminoglutetimid; Aminoglutetimida; Aminoglutetimidas; Aminoglutetimidi; Ba-16038 BAN: Aminoglutethimide INN: Aminoglutethimide [rINN (en)] INN: Aminoglutetimida [rINN (es)] INN: Aminoglutéthimide [rINN (fr)] INN: Aminoglutethimidum [rINN (la)] INN: Аминоглутетимид [rINN (ru)] Chemical name: 2-(4-Aminophenyl)-2-ethylglutarimide; 3-(4-Aminophenyl)-3-ethylpiperidine-2,6-dione Molecular formula: C13H16N2O2 =232.3 CAS: 125-84-8 ATC code: ... http://healthandprostate.com/index.php/drugs/aminoglutethimide (British Approved Name, US Adopted Name, rINN) Drug Nomenclature International Nonproprietary Names (INNs) in main languages (French, Latin, Russian, and Spanish): Synonyms: Nilutamid; Nilutamida; Nilutamidi; Nilutamidum; RU-23908 BAN: Nilutamide USAN: Nilutamide INN: Nilutamide [rINN (en)] INN: Nilutamida [rINN (es)] INN: Nilutamide [rINN (fr)] INN: Nilutamidum [rINN (la)] INN: Нилутамид [rINN (ru)] Chemical name: 5,5-Dimethyl-3-(α,α,α-trifluoro-4-nitro-m-tolyl)-imidazolidine-2,4-dione Molecular formula: C12H10F3N3O4 =317.2 CAS: 63612-50-0 ATC ... http://healthandprostate.com/index.php/drugs/nilutamide Prostate cancer is the second leading cause of death in men, with approximately 220,000 new cases and an expected 28,000 deaths in the year 2003. A decrease in prostate cancer related deaths has been attributed to early prostate-specific antigen (PSA) detection, more effective chemotherapy treatments, and immunotherapies. Although tumors can ... http://healthandprostate.com/index.php/pharmacotherapy/immunotherapies-for-prostate-cancer US Adopted Name, rINN Drug Nomenclature Synonyms: ORF-17070; RWJ-17070 USAN: Histrelin INN: Histrelin [rINN (en)] INN: Histrelina [rINN (es)] INN: Histréline [rINN (fr)] INN: Histrelinum [rINN (la)] INN: Гистрелин [rINN (ru)] Chemical name: 5-Oxo-l-prolyl-l-histidyl-l-tryptophyl-l-seryl-l-tyrosyl-Nτ-benzyl-d-histidyl-l-leucyl-l-argininyl-N-ethyl-l-prolinamide Molecular formula: C66H86N18O12 =1323.5 CAS: 76712-82-8 ATC code: H01CA03 Histrelin Acetate INN: Histrelin Acetate [rINNM (en)] INN: Acetato de histrelina [rINNM (es)] INN: Histréline, Acétate d' [rINNM (fr)] INN: Histrelini Acetas ... http://healthandprostate.com/index.php/drugs/histrelin Drug Approvals (British Approved Name, US Adopted Name, rINN) International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish): Synonyms: d-Trp6-LHRH; AY-25650; BIM-21003; BN-52014; CL-118532; Triptorelina; Triptoreline; [6-d-Tryptophan] luteinising hormone-releasing factor BAN: Triptorelin USAN: Triptorelin INN: Triptorelin [rINN (en)] INN: Triptorelina [rINN (es)] INN: Triptoréline [rINN (fr)] INN: Triptorelinum [rINN (la)] INN: Трипторелин [rINN (ru)] Chemical ... http://healthandprostate.com/index.php/drugs/triptorelin After the initiation of androgen deprivation therapy (ADT), most patients with prostate cancer will show some evidence of clinical response; the magnitude and rapidity of that response remain the best predictors of its durability. Assuming that ADT effectively targets the androgen-sensitive population of prostate ... http://healthandprostate.com/index.php/treatment/response-to-androgen-blockade There are four therapeutic approaches for androgen axis blockade in current clinical use: ablation of androgen sources, inhibition of androgen synthesis, antiandrogens, and inhibition of luteinizing hormone–releasing hormone (LHRH) or luteinizing hormone (LH) release ( Table: Therapeutic Approaches to Androgen Deprivation Therapy ). Table: Therapeutic Approaches to Androgen Deprivation ... http://healthandprostate.com/index.php/treatment/mechanisms-of-androgen-axis-blockade Testosterone is the major circulating androgen, with 90% produced by the testes. More than half of testosterone is bound to sex-binding globulin and 40% is bound to albumin. Only 3% of testosterone remains unbound, and this is the functionally active form of the hormone. After passive diffusion through the cell ... http://healthandprostate.com/index.php/treatment/sources-of-androgen The response of prostate cancer to androgen ablation is among the most reproducible, durable, and profound of any systemic therapy for a solid tumor. The early and frequent descriptions of the immediate relief of bone pain from metastatic prostate cancer after castration do not diminish the marvel of observing this ... http://healthandprostate.com/index.php/prostate-cancer/historic-overview-of-hormone-therapy-for-prostate-cancer